Cargando…

Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer’s disease: the Altoida large cohort study

Conventional neuropsychological assessments for Alzheimer’s disease are burdensome and inaccurate at detecting mild cognitive impairment and predicting Alzheimer’s disease risk. Altoida’s Digital Neuro Signature (DNS), a longitudinal cognitive test consisting of two active digital biomarker metrics,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meier, Irene B., Buegler, Max, Harms, Robbert, Seixas, Azizi, Çöltekin, Arzu, Tarnanas, Ioannis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225898/ https://www.ncbi.nlm.nih.gov/pubmed/34168269 http://dx.doi.org/10.1038/s41746-021-00470-z

Ejemplares similares

Associations of digital neuro-signatures with molecular and neuroimaging measures of brain resilience: The altoida large cohort study
por: Seixas, Azizi A., et al.
Publicado: (2022)

Can detection and prediction models for Alzheimer’s Disease be applied to Prodromal Parkinson’s Disease using explainable artificial intelligence? A brief report on Digital Neuro Signatures.
por: Tarnanas, Ioannis, et al.
Publicado: (2022)

Digital biomarkers and sex impacts in Alzheimer’s disease management — potential utility for innovative 3P medicine approach
por: Harms, Robbert L., et al.
Publicado: (2022)

Digital biomarker‐based individualized prognosis for people at risk of dementia
por: Buegler, Maximilian, et al.
Publicado: (2020)

Making pre-screening for Alzheimer's disease (AD) and Postoperative delirium among post-acute COVID-19 syndrome - (PACS) a national priority: The Deep Neuro Study
por: Tarnanas, Ioannis, et al.
Publicado: (2022)

Quantifying gaze and mouse interactions on spatial visual interfaces with a new movement analytics methodology
por: Demšar, Urška, et al.
Publicado: (2017)

Using Coefficient to Distinguish Ambient/Focal Visual Attention During Cartographic Tasks
por: Krejtz, Krzysztof, et al.
Publicado: (2017)

Neurological and mental health consequences of COVID-19: potential implications for well-being and labour force
por: Meier, Irene Beatrix, et al.
Publicado: (2021)

Ecological Validity of Virtual Reality Daily Living Activities Screening for Early Dementia: Longitudinal Study
por: Tarnanas, Ioannis, et al.
Publicado: (2013)

Five-year biomarker progression variability for Alzheimer's disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the gaps?
por: Tarnanas, Ioannis, et al.
Publicado: (2015)

Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials
por: Gold, Michael, et al.
Publicado: (2018)

Virtual environments as memory training devices in navigational tasks for older adults
por: Lokka, Ismini E., et al.
Publicado: (2018)

Digital Reconstruction of the Neuro-Glia-Vascular Architecture
por: Zisis, Eleftherios, et al.
Publicado: (2021)

Comparative Phosphoproteomics of Neuro-2a Cells under Insulin Resistance Reveals New Molecular Signatures of Alzheimer’s Disease
por: Kim, Dayea, et al.
Publicado: (2022)

Fusion of Neuro-Signals and Dynamic Signatures for Person Authentication
por: Kumar, Pradeep, et al.
Publicado: (2019)

Individual Patient Research (IPR) Outcomes with Alzheimer's Disease: The Psycho-neuro-immune Viewpoint
por: Chiappelli, Francesco, et al.
Publicado: (2016)

Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort
por: Aguilar, Carlos, et al.
Publicado: (2014)

Description of the Method for Evaluating Digital Endpoints in Alzheimer Disease Study: Protocol for an Exploratory, Cross-sectional Study
por: Curcic, Jelena, et al.
Publicado: (2022)

Interaction with Industrial Digital Twin Using Neuro-Symbolic Reasoning
por: Siyaev, Aziz, et al.
Publicado: (2023)

Microglia and Astrocytes in Neuro-Aids, Alzheimers Disease, and Multiple Sclerosis
por: Minagar, Alireza, et al.
Publicado: (2001)

Impact of Cytokines and Chemokines on Alzheimer’s Disease Neuro-pathological Hallmarks
por: Domingues, Catarina, et al.
Publicado: (2017)

Neurodegeneration and Neuro-Regeneration—Alzheimer’s Disease and Stem Cell Therapy
por: Vasic, Verica, et al.
Publicado: (2019)

Blood-based metabolic signatures in Alzheimer's disease
por: de Leeuw, Francisca A., et al.
Publicado: (2017)

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
por: Moussa, Charbel, et al.
Publicado: (2017)

Neuro-degeneration profile of Alzheimer's patients: A brain morphometry study
por: Ramos Bernardes da Silva Filho, Silvio, et al.
Publicado: (2017)

A Novel Concept is Needed for Combating Alzheimer’s Disease and NeuroHIV
por: Hu, Xiu-Ti
Publicado: (2020)

Clinical heterogeneity of neuro-inflammatory PET profiles in early Alzheimer’s disease
por: Gouilly, Dominique, et al.
Publicado: (2023)

Longitudinal Effects of Bumetanide on Neuro-Cognitive Functioning in Drug-Resistant Epilepsy
por: Gharaylou, Zeinab, et al.
Publicado: (2019)

Are you a good mimic? Neuro-acoustic signatures for speech imitation ability
por: Reiterer, Susanne M., et al.
Publicado: (2013)

Gene signature associated with neuro‐endocrine activity predicting prognosis of pancreatic carcinoma
por: Chen, Ke, et al.
Publicado: (2019)

Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology
por: Gatto, Lidia, et al.
Publicado: (2022)

Topological Filtering of Dynamic Functional Brain Networks Unfolds Informative Chronnectomics: A Novel Data-Driven Thresholding Scheme Based on Orthogonal Minimal Spanning Trees (OMSTs)
por: Dimitriadis, Stavros I., et al.
Publicado: (2017)

NeuroLive - Video-on-demand für die Neurologie
por: Meier, Uwe, et al.
Publicado: (2022)

Resources for Turkish natural language processing: A critical survey
por: Çöltekin, Çağrı, et al.
Publicado: (2022)

neuroRAD 2022: Precision. Individualized
por: Schramm, Peter, et al.
Publicado: (2022)

Review of Neuro-nutrition Used as Anti-Alzheimer Plant, Spinach, Spinacia oleracea
por: Jiraungkoorskul, Wannee
Publicado: (2016)

Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer’s Disease: Are We There Yet?
por: Raikwar, Sudhanshu P., et al.
Publicado: (2018)

Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage
por: Jia, Longfei, et al.
Publicado: (2020)

The Gap Between AI and Bedside: Participatory Workshop on the Barriers to the Integration, Translation, and Adoption of Digital Health Care and AI Startup Technology Into Clinical Practice
por: Olaye, Iredia M, et al.
Publicado: (2023)

Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals
por: Chipi, Elena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_grp0b5ouhb2ghnkloe38eoh6k5